← All stocks

NeuroPace Inc

NPCE Net selling

CIK 0001528287 #3149 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$399.25K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$399.25K

1 of 1 sales

Net

−$399.25K

−$399.25K against sales at will

By person

13 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Morrell Martha

CHIEF MEDICAL OFFICER

—

$399.25K (1)

−$399.25K

51,692

0.1506%

$825.52K

−70.4%

ORBIMED ADVISORS LLC entity

10% owner

—

3,238,199

9.43%

$51.71M

−4.9%

Fischer Frank M

Director

—

599,534

1.75%

$9.57M

+3.4%

Becker Joel

CHIEF EXECUTIVE OFFICER

—

138,000

0.4020%

$2.20M

+163.0%

Kuhn Rebecca

CHIEF FINANCIAL OFFICER

—

131,613

0.3834%

$2.10M

−3.2%

Williams Patrick F.

Chief Financial Officer

—

68,670

0.2001%

$1.10M

—

Kumar Rakhi

Director

—

23,039

0.0671%

$367.93K

+143.7%

Geiger Uri

Director

—

18,537

0.0540%

$296.04K

+158.3%

LACOB JOSEPH

Director

—

14,754

0.0430%

$235.62K

+97.4%

Huennekens R Scott

Director

—

2,890

0.0084%

$46.15K

—

Ryan Renee

Director

—

2,890

0.0084%

$46.15K

—

Andrade Lisa

Director

—

2,890

0.0084%

$46.15K

—

KCK LTD. entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 41

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 127,793

History held since 23 Apr 2021